Cancer immunomics using autoantibody signatures for biomarker discovery

Molecular and Cellular Proteomics

Volumn 6, Issue 7, 2007, Pages 1115-1122

  Caron, Michel ^a   Choquet Kastylevsky, Geneviève ^b   Joubert Caron, Raymonde ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b Advanced Technology Unit   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LIPOCORTIN 1; LIPOCORTIN 2; MYC PROTEIN; PROTEIN P53; TUMOR ANTIGEN; TUMOR PROTEIN;

ANTIBODY DETECTION; ANTIGEN DETECTION; ANTIGEN PURIFICATION; ANTIGEN RECOGNITION; BLOOD ANALYSIS; CANCER IMMUNOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOAFFINITY CHROMATOGRAPHY; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; AUTOANTIBODIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 34547137152     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.R600016-MCP200     Document Type: Review

References (52)

1. Tan, E. M. (2001) Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J. Clin. Investig. 108, 1411-1415
2. Finn, O. J. (2005) Immune response as a biomarker for cancer detection and a lot more. N. Engl. J. Med. 353, 1288-1290
3. Canevari, S., Pupa, S. M., and Menard, S. (1996) 1975-1995 revised anti-cancer serological response: biological significance and clinical implications. Ann. Oncol. 7, 227-232
4. Purcell, A. W., and Gorman, J. J. (2004) Immunoproteomics: mass spectrometry-based methods to study the targets of the immune response. Mol. Cell. Proteomics 3, 193-208
5. Boon, T., and Old, L. J. (1997) Cancer tumor antigens. Curr. Opin. Immunol. 9, 681-683
6. Naora, H., Yang, Y. Q., Montz, F. J., Seidman, J. D., Kurman, R. J., and Roden, R. B. (2001) A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 98, 4060-4065
7. Scanlan, M. J., Welt, S., Gordon, C. M., Chen, Y. T., Gure, A. O., Stockert, E., Jungbluth, A. A., Ritter, G., Jager, D., Jager, E., Knuth, A., and Old, L. J. (2002) Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res. 62, 4041-4047
8. Sahin, U., Tureci, O., and Pfreundschuh, M. (1997) Serological identification of human tumor antigens. Curr. Opin. Immunol. 9, 709-716
9. Bradford, T. J., Wang, X., and Chinnaiyan, A. M. (2006) Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer. Urol. Oncol. 24, 237-242
10. Soussi, T. (2000) p53 Antibodies in the sera of patients with various types of cancer: a review. Cancer Res. 60, 1777-1788
11. Yamamoto, A., Shimizu, E., Sumitomo, K., Shinohara, A., Namikawa, O., Uehara, H., and Sone, S. (11997) L-Myc overexpression and detection of auto-antibodies against L-Myc in both the serum and pleural effusion from a patient with non-small cell lung cancer. Intern. Med. 36, 724-727
12. Brichory, F. M., Misek, D. E., Yim, A. M., Krause, M. C., Giordano, T. J., Beer, D. G., and Hanash, S. M. (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl. Acad. Sci. U. S. A. 98, 9824-9829
13. Ward, R. L., Hawkins, N. J., Coomber, D., and Disis, M. L. (1999) Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer. Hum. Immunol. 60, 510-515
14. Shiku, H., Takahashi, T., Resnick, L. A., Oettgen, H. F., and Old, L. J. (1977) Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J. Exp. Med. 145, 784-789
15. Old, L. J., and Chen, Y. T. (1998) New paths in human cancer serology. J. Exp. Med. 187, 1163-1167
16. Stockert, E., Jager, E., Chen, Y. T., Scanlan, M. J., Gout, I., Karbach, J., Arand, M., Knuth, A., and Old, L. J. (1998) A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187, 1349-1354
17. Wang, X., Yu, J., Sreekumar, A., Varambally, S., Shen, R., Giacherio, D., Mehra, R., Montie, J. E., Pienta, K. J., Sanda, M. G., Kantoff, P. W., Rubin, M. A., Wei, J. T., Ghosh, D., and Chinnaiyan, A. M. (2005) Autoantibody signatures in prostate cancer. N. Engl. J. Med. 353, 1224-1235
18. Canelle, L., Bousquet, J., Pionneau, C., Deneux, L., Imam-Sghiouar, N., Caron, M., and Joubert-Caron, R. (2005) An efficient proteomics-based approach for the screening of autoantibodies. J. Immunol. Methods 299, 77-89
19. Jager, E., Jager, D., and Knuth, A. (1999) CTL-defined cancer vaccines: perspectives for active immunotherapeutic interventions in minimal residual disease. Cancer Metastasis Rev. 18, 143-150
20. Scanlan, M. J., Chen, Y. T., Williamson, B., Gure, A. O., Stockert, E., Gordan, J. D., Tureci, O., Sahin, U., Pfreundschuh, M., and Old, L. J. (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int. J. Cancer 76, 652-658
21. Klade, C. S., Voss, T., Krystek, E., Ahorn, H., Zatloukal, K., Pummer, K., and Adolf, G. R. (2001) Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 1, 890-898
22. Le Naour, F., Misek, D. E., Krause, M. C., Deneux, L., Giordano, T. J., Scholl, S., and Hanash, S. M. (2001) Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res. 7, 3328-3335
23. Xiang, Y., Sekine, T., Nakamura, H., Imajoh-Ohmi, S., Fukuda, H., Nishioka, K., and Kato, T. (2004) Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum. 50, 1511-1521
24. Fulton, R. J., McDade, R. L., Smith, P. L., Kienker, L. J., and Kettman, J. R., Jr. (1997) Advanced multiplexed analysis with the FlowMetrix system. Clin. Chem. 43, 1749-1756
25. Nicewamer-Pena, S. R., Freeman, R. G., Reiss, B. D., He, L., Pena, D. J., Walton, I. D., Cromer, R., Keating, C. D., and Natan, M. J. (2001) Submicrometer metallic barcodes. Science 294, 137-141
26. Seliger, B., and Kellner, R. (2002) Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets. Proteomics 2, 1641-1651
27. Seliger, B., Lichtenfels, R., and Kellner, R. (2003) Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses. Brief. Funct. Genomics Proteomics 2, 194-212
28. Ishida, K., Kaneko, K., Kubota, T., Itoh, Y., Miyatake, T., Matsushita, M., and Yamada, M. (1997) Identification and characterization of an anti-glial fibrillary acidic protein antibody with a unique specificity in a demented patient with an autoimmune disorder. J. Neurol. Sci. 151, 41-48
29. Geissler, S., Sokolowska-Kohler, W., Bollmann, R., Jungblut, P. R., and Presber, W. (1999) Toxoplasma gondii infection: analysis of serological response by 2-DE immunoblotting. FEMS Immunol. Med. Microbiol. 25, 299-311
30. Petersen, A. (2003) Two-dimensional electrophoresis replica blotting: a valuable technique for the immunological and biochemical characterization of single components of complex extracts. Proteomics 3, 1206-1214
31. Stulik, J., Hernychova, L., Porkertova, S., Pozler, O., Tuckova, L., Sanchez, D., and Bures, J. (2003) Identification of new celiac disease autoantigens using proteomic analysis. Proteomics 3, 951-956
32. Canelle, L., Bousquet, J., Pionneau, C., Hardouin, J., Choquet-Kastylevsky, G., Joubert-Caron, R., and Caron, M. (2006) A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins. Electrophoresis 27, 1609-1616
33. Pionneau, C., Canelle, L., Bousquet, J., Hardouin, J., Bigeard, J., Caron, M., and Joubert-Caron, R. (2005) Proteomic analysis of membrane-associated proteins from the breast cancer cell line MCF7. Cancer Genomics Proteomics 2, 199-208
34. Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., and Thun, M. J. (2004) Cancer statistics, 2004. CA Cancer J. Clin. 54, 8-29
35. Brichory, F., Beer, D., Le Naour, F., Giordano, T., and Hanash, S. (2001) Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res. 61, 7908-7912
36. Nam, M. J., Madoz-Gurpide, J., Wang, H., Lescure, P., Schmalbach, C. E., Zhao, R., Misek, D. E., Kuick, R., Brenner, D. E., and Hanash, S. M. (2003) Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 3, 2108-2115
37. Nam, M. J., Kee, M. K., Kuick, R., and Hanash, S. M. (2005) Identification of defensin α6 as a potential biomarker in colon adenocarcinoma. J. Biol. Chem. 280, 8260-8265
38. Livingston, P. O., Ragupathi, G., and Musselli, C. (2000) Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues. J. Clin. Immunol. 20, 85-93
39. Tontsch, D., Pankuweit, S., and Maisch, B. (2000) Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Clin. Exp. Immunol. 121, 270-274
40. Caron, M., Joubert-Caron, R., Canelle, L., and Hardouin, J. (2005) Serological proteome analysis (SERPA) and multiple affinity protein profiling (MAPPING) to discover cancer biomarkers. Mol. Cell. Proteomics 4, (suppl.) S142
41. Hardouin, J., Duchateau, M., Canelle, L., Vlieghe, C., Joubert-Caron, R., and Caron, M. (2007) Thiophilic adsorption revisited. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 845, 226-231
42. Yin, H., Killeen, K., Brennen, R., Sobek, D., Werlich, M., and van de Goor, T. (2005) Microfluidic chip for peptide analysis with an integrated HPLC column, sample enrichment column, and nanoelectrospray tip. Anal. Chem. 77, 527-533
43. Hardouin, J., Duchateau, M., Joubert-Caron, R., and Caron, M. (2006) Usefulness of an integrated microfluidic device (HPLC-Chip-MS) to enhance confidence in protein identification by proteomics. Rapid Commun. Mass Spectrom. 20, 3236-3244
44. Sheehan, K. M., Calvert, V. S., Kay, E. W., Lu, Y., Fishman, D., Espina, V., Aquino, J., Speer, R., Araujo, R., Mills, G. B., Liotta, L. A., Petricoin, E. F., III, and Wulfkuhle, J. D. (2005) Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell. Proteomics 4, 346-355
45. Robinson, W. H., Steinman, L., and Utz, P. J. (2003) Protein arrays for autoantibody profiling and fine-specificity mapping. Proteomics 3, 2077-2084
46. Lueking, A., Horn, M., Eickhoff, H., Bussow, K., Lehrach, H., and Walter, G. (1999) Protein microarrays for gene expression and antibody screening. Anal. Biochem. 270, 103-111
47. Joos, T. O., Schrenk, M., Hopfl, P., Kroger, K., Chowdhury, U., Stoll, D., Schorner, D., Durr, M., Herick, K., Rupp, S., Sohn, K., and Hammerle, H. (2000) A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics. Electrophoresis 21, 2641-2650
48. Qiu, J., Madoz-Gurpide, J., Misek, D. E., Kuick, R., Brenner, D. E., Michailidis, G., Haab, B. B., Omenn, G. S., and Hanash, S. (2004) Development of natural protein microarrays for diagnosing cancer based on an anti-body response to tumor antigens. J. Proteome Res. 3, 261-267
49. Qin, S., Qiu, W., Ehrlich, J. R., Ferdinand, A. S., Richie, J. P., O'Leary M, P., Lee, M. L., and Liu, B. C. (2006) Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling. Proteomics 6, 3199-3209
50. Wilkins, M. R., Appel, R. D., Van Eyk, J. E., Chung, M. C., Gorg, A., Hecker, M., Huber, L. A., Langen, H., Link, A. J., Paik, Y. K., Patterson, S. D., Pennington, S. R., Rabilloud, T., Simpson, R. J., Weiss, W., and Dunn, M. J. (2006) Guidelines for the next 10 years of proteomics. Proteomics 6, 4-8
51. Zweig, M. H., and Campbell, G. (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39, 561-577
52. Zhong, L., Peng, X., Hidalgo, G. E., Doherty, D. E., Stromberg, A. J., and Hirschowitz, E. A. (2004) Identification of circulating antibodies to tumor-associated proteins for combined use as markers of non-small cell lung cancer. Proteomics 4, 1216-1225